First patients test new hope for advanced cancers
NCT ID NCT06993116
Summary
This is the first study in people to test a new drug called SHR-4712 for advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. A small group of patients will receive the drug until side effects become too severe or their cancer gets worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350014, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.